Abstract
Type 1 diabetes mellitus (T1DM) is a chronic condition requiring lifelong management that affects a large number of children and adolescents globally. While diabetes care has improved over the years, low-middle income countries, such as Indonesia, still struggle to achieve optimal diabetes care due to limited access to healthcare professionals, insulin, diabetes technologies, and self-monitoring blood glucose (SMBG) devices. Data from the Indonesian Pediatric Society registry has reflected a stark increase in the number of children with T1DM, with the current prevalence significantly concentrated on Java island and a noticeable underreporting in rural regions. Another major challenge is the uneven distribution of pediatric endocrinologists, resulting in a low specialist-to-patient ratio. This imbalance, coupled with inadequate access to comprehensive diabetes care, complicates effective T1DM management. While the national insurance covers a portion of costs associated with T1DM care, vital aspects of T1DM management including SMBG devices are still not covered, resulting in significant financial burden to families. Access to diabetes technologies that improve glycemic control and quality of life of patients is also still largely limited. This paper evaluates the current state and future needs for insulin and SMBG in Indonesia, emphasizing the necessity of strategic interventions to improve access and quality of diabetes care.
Keywords: Pediatric, type 1 diabetes, challenges, practice
Read the full text
2 sections · 3 figures · 2 tables · PDF
Create your free account to read the full text.
- Full text with figures and tables
- PDF and supplementary files
- Access on every Galenos journal
One Galenos account works on every Galenos journal site.
References
Pulungan AB, de Beaufort C, Ratnasari AF, Puteri HA, Lewis-Watts L, Bhutta ZA. Availability and access to pediatric diabetes care: a global descriptive study. Clin Pediatr Endocrinol. 2023;32:137-146. Epub 2023 Apr 19
Klatman EL, Ogle GD. Access to insulin delivery devices and glycated haemoglobin in lower-income countries. World J Diabetes. 2020;11:358-369.
Saiyed M, Hasnani D, Alonso GT, Richmond E, Besançon S, Cotterill A, Ngwu U, Mazza C, Rottembourg D, Lanzinger S; SWEET study group. Worldwide differences in childhood type 1 diabetes: the SWEET experience. Pediatr Diabetes. 2021;22:207-214. Epub 2020 Oct 22
Changing diabetes in children Indonesia. Patient Registry. Jakarta; 2024.
Indonesian Pediatric Society. Database of the Endocrinology Working Group, 2023.
Endocrinology Working Group of the Indonesian Pediatric Society. National Pediatric Diabetes Registry. Jakarta; 2024.
Department of economic and social affairs PDUN. World population prospects 2024. United Nations. 2024. https://population.un.org/wpp/
Federal Ministry of Health. Health and health related indicators. Ethiopia; 2011.
Mills A. Health care systems in low- and middle-income countries. N Engl J Med. 2014;370:552-557.
Chanoine JP, Stafford D. Global health for the paediatric endocrinologist. Yearbook of Paediatric Endocrinology; 2023.
Sow A, Boiro D, Sow PS, Niang B, Mbaye A, Barrage AL, Fall AL, Dieye S, Sow NF, Gueye M, Mbaye MN, Ndiaye O. Insulin therapy in childhood type 1 diabetes: Knowledge and practice in Senegal. Arch Pediatr. 2021;28:307-310. Epub 2021 Mar 11
Cengiz E, Danne T, Ahmad T, Ayyavoo A, Beran D, Ehtisham S, Fairchild J, Jarosz-Chobot P, Ng SM, Paterson M, Codner E. ISPAD Clinical Practice Consensus Guidelines 2022: insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2022;23:1277-1296.
Sherr JL, Schoelwer M, Dos Santos TJ, Reddy L, Biester T, Galderisi A, van Dyk JC, Hilliard ME, Berget C, DiMeglio LA. ISPAD Clinical Practice Consensus Guidelines 2022: diabetes technologies: insulin delivery. Pediatr Diabetes. 2022;23:1406-1431. Epub 2022 Dec 5
Changing diabetes in children Indonesia. Insulin data 2024. Jakarta; 2024.
Pulungan AB, Julia M, Batubara JRL, Hermanussen M. Indonesian national synthetic growth charts. Acta Sci Paediatr. 2018;1:20-34.
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, Pavkov ME, Ramachandaran A, Wild SH, James S, Herman WH, Zhang P, Bommer C, Kuo S, Boyko EJ, Magliano DJ. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. Epub 2021 Dec 6. Erratum in: Diabetes Res Clin Pract. 2023;204:110945. Epub 2023 Oct 19
Al-Beltagi M, Saeed NK, Bediwy AS, Elbeltagi R. Insulin pumps in children - a systematic review. World J Clin Pediatr. 2022;11:463-484.
Marks BE, Wolfsdorf JI. Monitoring of Pediatric Type 1 Diabetes. Front Endocrinol (Lausanne). 2020;11:128.
Tauschmann M, Forlenza G, Hood K, Cardona-Hernandez R, Giani E, Hendrieckx C, DeSalvo DJ, Laffel LM, Saboo B, Wheeler BJ, Laptev DN, Yarhere I, DiMeglio LA. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring. Pediatr Diabetes. 2022;23:1390-1405.
Rochmah N, Hisbiyah Y, Perwitasari RK, Rosaningrum J, Wicaksono G, Kusumastuti NP, et al. Quality of life, medication adherence, and glycemic control in type 1 diabetes mellitus children with basal bolus regimen during COVID-19 in limited resources setting. J Compr Ped. 2023;14:e134561.
Rodbard D. Continuous glucose monitoring: a review of successes, challenges, and opportunities. Diabetes Technol Ther. 2016;18(Suppl 2):3-13.
Jiao Y, Lin R, Hua X, Churilov L, Gaca MJ, James S, Clarke PM, O’Neal D, Ekinci EI. A systematic review: cost-effectiveness of continuous glucose monitoring compared to self-monitoring of blood glucose in type 1 diabetes. Endocrinol Diabetes Metab. 2022;5:e369. Epub 2022 Sep 16
Funtanilla VD, Candidate P, Caliendo T, Hilas O. Continuous glucose monitoring: a review of available systems. P T. 2019;44:550-553.
Chiang JL, Maahs DM, Garvey KC, Hood KK, Laffel LM, Weinzimer SA, Wolfsdorf JI, Schatz D. Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association. Diabetes Care. 2018;41:2026-2044. Epub 2018 Aug 9
Wherrett DK, Chiang JL, Delamater AM, DiMeglio LA, Gitelman SE, Gottlieb PA, Herold KC, Lovell DJ, Orchard TJ, Ryan CM, Schatz DA, Wendler DS, Greenbaum CJ; Type 1 Diabetes TrialNet Study Group. Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report. Diabetes Care. 2015;38:1975-1985.
Adu MD, Malabu UH, Malau-Aduli AEO, Malau-Aduli BS. Enablers and barriers to effective diabetes self-management: a multi-national investigation. PLoS One. 2019;14:e0217771.
Himawan IW, Pulungan AB, Tridjaja B, Batubara JRL. Komplikasi Jangka Pendek dan Jangka Panjang Diabetes Mellitus Tipe 1. Sari Pediatri. 2016;10:367-372.
Agustina R, Dartanto T, Sitompul R, Susiloretni KA, Suparmi, Achadi EL, Taher A, Wirawan F, Sungkar S, Sudarmono P, Shankar AH, Thabrany H; Indonesian Health Systems Group. Universal health coverage in Indonesia: concept, progress, and challenges. Lancet. 2019;393:75-102. Epub 2018 Dec 19
Indonesia BPS. Rata-Rata Upah/Gaji (Rupiah), 2023. Badan Pusat Statistik, 2024.
Willner S, Whittemore R, Keene D. “Life or death”: experiences of insulin insecurity among adults with type 1 diabetes in the United States. SSM Popul Health. 2020;11:100624.
Novo Nordisk. Changing diabetes in children programme for children with type 1 diabetes. Novo Nordisk, 2024.
PrimaKu: Pelopor Aplikasi Tumbuh Kembang Anak. 2024.
SATUSEHAT: Ekosistem Data Kesehatan Indonesia. 2024.
Lindholm Olinder A, DeAbreu M, Greene S, Haugstvedt A, Lange K, Majaliwa ES, Pais V, Pelicand J, Town M, Mahmud FH. ISPAD Clinical Practice Consensus Guidelines 2022: diabetes education in children and adolescents. Pediatr Diabetes. 2022;231229-1242.
Soewondo P, Ferrario A, Tahapary DL. Challenges in diabetes management in Indonesia: a literature review. Global Health. 2013;9:63.
Limbert C, Tinti D, Malik F, Kosteria I, Messer L, Jalaludin MY, Benitez-Aguirre P, Biester S, Corathers S, von Sengbusch S, Marcovecchio ML. ISPAD Clinical Practice Consensus Guidelines 2022: the delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatr Diabetes. 2022;23:1243-1269.


